Idiopathic inflammatory myopathies

IE Lundberg, M Fujimoto, J Vencovsky… - Nature Reviews …, 2021 - nature.com
Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …

Anabolic–androgenic steroids: How do they work and what are the risks?

P Bond, DL Smit, W de Ronde - Frontiers in Endocrinology, 2022 - frontiersin.org
Anabolic–androgenic steroids (AAS) are a class of hormones that are widely abused for
their muscle-building and strength-increasing properties in high, nontherapeutic, dosages …

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

AFG Cicero, A Colletti, G Bajraktari… - Nutrition …, 2017 - academic.oup.com
In recent years, there has been growing interest in the possible use of nutraceuticals to
improve and optimize dyslipidemia control and therapy. Based on the data from available …

The role of nutraceuticals in statin intolerant patients

M Banach, AM Patti, RV Giglio, AFG Cicero… - Journal of the American …, 2018 - jacc.org
Statins are the most common drugs administered for patients with cardiovascular disease.
However, due to statin-associated muscle symptoms, adherence to statin therapy is …

Nutraceuticals in the management of dyslipidemia: which, when, and for whom? Could nutraceuticals help low-risk individuals with non-optimal lipid levels?

AFG Cicero, F Fogacci, AP Stoian, M Vrablik… - Current atherosclerosis …, 2021 - Springer
Abstract Purpose of Review The aim of this review is to summarize the available clinical
efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals …

Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group Update (2016)

GBJ Mancini, S Baker, J Bergeron, D Fitchett… - Canadian Journal of …, 2016 - Elsevier
Abstract The Canadian Consensus Working Group has updated its evaluation of the
literature pertaining to statin intolerance and adverse effects. This overview introduces a …

[HTML][HTML] A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults

T Osadnik, M Goławski, P Lewandowski, J Morze… - Pharmacological …, 2022 - Elsevier
It is estimated that 2.6 million deaths worldwide can be attributed to hypercholesterolemia.
The main reason for non-adherence to statin therapy are the statin-associated muscle …

Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach

AFG Cicero, F Fogacci, A Colletti - Food & function, 2017 - pubs.rsc.org
Cardiovascular diseases (CVDs) are one of the major causes of mortality and disability in
Western countries. Prevention is known to be the cornerstone to lessen the incidence of …

[HTML][HTML] 2017 Taiwan lipid guidelines for high risk patients

YH Li, KC Ueng, JS Jeng, MJ Charng, TH Lin… - Journal of the Formosan …, 2017 - Elsevier
In Taiwan, the prevalence of hyperlipidemia increased due to lifestyle and dietary habit
changes. Low density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein …

[HTML][HTML] Red yeast rice for hypercholesterolemia

AFG Cicero, F Fogacci, M Banach - Methodist DeBakey …, 2019 - ncbi.nlm.nih.gov
The extract of red yeast rice (RYR) is the most effective cholesterol-lowering nutraceutical on
the market. In particular, its effectiveness is directly related to the amount of monacolin K …